Page 3 - First Occurrence News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amarin Reports Encouraging Efficacy and Safety Results from Pilot Study Treating COVID-19 ... Amarin Corporation plcDecember 13, 2020 GMT VASCEPA COVID-19 CardioLink-9 Randomized Trial suggests improvement in patient-reported COVID-19 symptoms while achieving its primary endpoint by demonstrating a 25% reduction in high-sensitivity C-reactive protein (hsCRP) with encouraging short-term safety and tole...